All 26 patients with a clinical diagnosis of SPENCD/SPENCDI harboured homozygous or compound heterozygous ACP5 mutations (Table 1, Fig. 1). This evidence concerns the gene ACP5 and Spondyloenchondrodysplasia with immune dysregulation.